RE: my two bits I feel your pain Jentai ... but I disagree about your Chinese asessment.
Going into a market rife with corruption and counterfeit, it shows good street smarts that they took a very strong partner who has boat loads of the best lawyers and big vaults of money to back them up. If Medicago had tried to run that market by themselves, the Chinese would have eaten them for lunch.
Additionally, as I understand it, the Chinese market for vaccines is relatively small compared to a more developed country (even with China's vast population, very few people get vaccines).
So, taking into account Medicago's considerable opportunities for long term Chinese royalties while PMI handles all the misery and marketing risks, this provide great income support, affording Medicago to go after the much more lucrative markets. They certainly have not given away the farm!
That said - getting the word out better to support the share price is long overdue. There are too many past PP holders here with their own agendas, for this stock to be left unshaparoned any longer. IMHO, Paradigm certainly no longer fits the market maker bill.